Sumitomo Pharma (DNPUF) News Today $6.34 0.00 (0.00%) As of 07/11/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort InterestBuy This Stock DNPUF Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period DNPUF Sumitomo Pharma Co., Ltd. - Seeking AlphaJune 27, 2025 | seekingalpha.comSumitomo Pharma Restructures Asian Business with Marubeni PartnershipMay 28, 2025 | tipranks.comSumitomo Chemical Reports Financial Variances in SubsidiariesMay 14, 2025 | msn.comSumitomo Dainippon Pharma FY Net Y23.63B Vs Loss Y314.97BMay 13, 2025 | marketwatch.comSumitomo Pharma Proposes Amendments to Enhance GovernanceMay 12, 2025 | tipranks.comSumitomo Pharma Poised to Jump on Stem Cell Research ResultsApril 17, 2025 | bloomberg.comJefferies Sticks to Their Buy Rating for Sumitomo Dainippon Pharma Co (DNPUF)April 7, 2025 | markets.businessinsider.comSumitomo Pharma Extends Executive Pay Cuts Amid Financial ChallengesApril 4, 2025 | tipranks.comSumitomo Pharma to Enhance Governance with New Audit Committee StructureMarch 28, 2025 | tipranks.comSumitomo Pharma Refinances Borrowings to Stabilize FinancesMarch 25, 2025 | tipranks.comJefferies lifts Sumitomo Pharma stock rating to Buy, targets JPY900February 3, 2025 | msn.comSumitomo Pharma and Janssen Collaborate on Schizophrenia Medications in JapanJanuary 20, 2025 | tipranks.comSumitomo Dainippon Pharma Reports Improved FinancialsNovember 1, 2024 | markets.businessinsider.comSumitomo Pharma Streamlines Workforce with Retirement ProgramOctober 30, 2024 | markets.businessinsider.comSumitomo Pharma Reports Significant Forex LossesOctober 30, 2024 | markets.businessinsider.comNWPHF Newron Pharmaceuticals S.p.A.October 17, 2024 | seekingalpha.comSumitomo Pharma Co. Ltd.October 8, 2024 | wsj.comJapan's Sumitomo Corp enters renewable energy market in IndiaSeptember 13, 2024 | reuters.comJapanese pharma stocks surge to record highs after market routAugust 26, 2024 | finance.yahoo.comSumitomo Dainippon Pharma earnings: here's what Wall Street expectsJuly 30, 2024 | markets.businessinsider.comSMDPY Sumitomo Pharma Co., Ltd.May 22, 2024 | seekingalpha.comSumitomo Dainippon Pharma is about to announce its earnings — here's what to expectMay 14, 2024 | markets.businessinsider.comSumitomo Corporation: Still Neutral After Reviewing Results And Financial TargetsMay 9, 2024 | seekingalpha.comJapan's Sumitomo Corp net profit down 32% on Madagascar one-off lossMay 2, 2024 | msn.comJapan's Sumitomo plans $1.3 billion renewable power storage network, Nikkei reportsApril 23, 2024 | reuters.comSeaTwirl partners Sumitomo to promote vertical-axis wind turbines in JapanApril 3, 2024 | msn.comSumitomo subsidiary Sunstate acquires TSRMarch 29, 2024 | msn.comJapanese pharma with North Carolina offices to lay off 400March 6, 2024 | bizjournals.comSumitomo Pharma Cuts 400 US Jobs as Credit Market Concerns MountMarch 5, 2024 | bloomberg.comSumitomo Dainippon Pharma Co Ltd (4506)January 30, 2024 | uk.investing.comSumitomo Pharma Co Ltd 4506December 19, 2023 | morningstar.comMSumitomo Pharma America and Actress Holly Robinson Peete Extend Time To Go™ Campaign to Empower People with Overactive BladderNovember 21, 2023 | markets.businessinsider.comHealth Canada approves Sumitomo’s prostate cancer treatmentOctober 24, 2023 | msn.comSignal: Sumitomo invests in Nano One Materials CorpOctober 2, 2023 | msn.comSalipro Biotech enters into research collaboration with Sumitomo Pharma to advance a drug discovery programSeptember 12, 2023 | technews.tmcnet.comHere's what Wall Street expects from Sumitomo Dainippon Pharma's earningsJuly 30, 2023 | markets.businessinsider.comGinkgo Bioworks and Sumitomo Chemical Announce Expanded Partnership To Develop Functional Chemicals with Synthetic BiologyJuly 18, 2023 | technews.tmcnet.comSumitomo Metal IndustriesJune 24, 2023 | forbes.comSumitomo Dainippon Pharma (TYO:4506) Price Target Decreased by 10.51% to 868.46June 1, 2023 | msn.com3 Pharma Stocks That Will Boom Thanks to AIMay 26, 2023 | markets.businessinsider.comSunovion, Sumitomo To Lay Off 223 At Marlborough OfficesMay 2, 2023 | msn.comSumitomo Pharma Subsidiary Companies in the U.S., Including Sunovion, to Combine and Form Sumitomo Pharma AmericaApril 3, 2023 | benzinga.comSumitomo Pharma Subsidiary Companies in the U.S., Including Sumitomo Pharma Oncology, to Combine and Form Sumitomo Pharma AmericaApril 3, 2023 | markets.businessinsider.comNippon Paper, others look at making sustainable aviation fuel from woodFebruary 3, 2023 | reuters.comJapan’s Sumitomo Mitsui Boosts Stake In Philippines’ RCBC With $460 Million InvestmentNovember 3, 2022 | forbes.comSumitomo Pharma Co., Ltd. (DNPUF)October 20, 2022 | finance.yahoo.comRevisiting Myovant... October 4, 2022 | markets.businessinsider.comSumitomo Offers to Buy All of Myovant in Deal Worth $2.5 BillionOctober 3, 2022 | bloomberg.comSumitomo Pharma Co LtdSeptember 9, 2022 | reuters.comJapan's Sumitomo Mitsui reports Q1 profit jump, Mizuho suffers dropJuly 30, 2022 | reuters.com Get Sumitomo Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for DNPUF and its competitors with MarketBeat's FREE daily newsletter. Email Address DNPUF Media Mentions By Week DNPUF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DNPUF News Sentiment▼0.001.01▲Average Medical News Sentiment DNPUF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DNPUF Articles This Week▼00▲DNPUF Articles Average Week Get Sumitomo Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for DNPUF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies 1933 Industries News Today 4Front Ventures News Today AB Science News Today Almirall News Today Amazonas Florestal News Today American Green News Today Avant Brands News Today Avicanna News Today BioSyent News Today Cannabis Global News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:DNPUF) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sumitomo Pharma Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sumitomo Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.